By type, the neuropathic pain market is segmented into peripheral neuropathy, entrapment neuropathy, post-traumatic neuropathy, phantom limb pain, post-herpetic neuralgia (PHN), and trigeminal neuralgia.

The rising prevalence of chronic diseases such as diabetes and cancer that triggers neuropathic pain is a major factor responsible for driving the growth of the market.

Neuropathic pain caused by damage or disease affecting the somatosensory nervous structure. The neuropathic pain may be associated with abnormal sensations known as dysesthesia pain.